AMBUJACEM Stock Overview
Manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Ambuja Cements Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹571.10 |
| 52 Week High | ₹706.95 |
| 52 Week Low | ₹453.05 |
| Beta | 0.24 |
| 1 Month Change | 4.89% |
| 3 Month Change | -7.90% |
| 1 Year Change | 9.33% |
| 3 Year Change | 58.00% |
| 5 Year Change | 190.56% |
| Change since IPO | 1,331.09% |
Recent News & Updates
These 4 Measures Indicate That Ambuja Cements (NSE:AMBUJACEM) Is Using Debt Reasonably Well
Dec 14
We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings
Nov 08Calculating The Fair Value Of Ambuja Cements Limited (NSE:AMBUJACEM)
Oct 31Recent updates
These 4 Measures Indicate That Ambuja Cements (NSE:AMBUJACEM) Is Using Debt Reasonably Well
Dec 14We Think That There Are Issues Underlying Ambuja Cements' (NSE:AMBUJACEM) Earnings
Nov 08Calculating The Fair Value Of Ambuja Cements Limited (NSE:AMBUJACEM)
Oct 31Some Shareholders Feeling Restless Over Ambuja Cements Limited's (NSE:AMBUJACEM) P/E Ratio
Oct 11Ambuja Cements (NSE:AMBUJACEM) May Have Issues Allocating Its Capital
Sep 14Here's Why Ambuja Cements (NSE:AMBUJACEM) Can Manage Its Debt Responsibly
Jul 23Returns On Capital At Ambuja Cements (NSE:AMBUJACEM) Have Stalled
May 30Ambuja Cements' (NSE:AMBUJACEM) Promising Earnings May Rest On Soft Foundations
May 09There's Reason For Concern Over Ambuja Cements Limited's (NSE:AMBUJACEM) Price
Apr 22Ambuja Cements (NSE:AMBUJACEM) Hasn't Managed To Accelerate Its Returns
Feb 01Is Ambuja Cements (NSE:AMBUJACEM) A Risky Investment?
Dec 21Shareholder Returns
| AMBUJACEM | IN Basic Materials | IN Market | |
|---|---|---|---|
| 7D | -0.4% | 1.3% | 0.2% |
| 1Y | 9.3% | 11.8% | 23.9% |
Return vs Industry: AMBUJACEM underperformed the Indian Basic Materials industry which returned 11.8% over the past year.
Return vs Market: AMBUJACEM underperformed the Indian Market which returned 23.9% over the past year.
Price Volatility
| AMBUJACEM volatility | |
|---|---|
| AMBUJACEM Average Weekly Movement | 5.1% |
| Basic Materials Industry Average Movement | 5.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: AMBUJACEM has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: AMBUJACEM's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 3,548 | Ajay Kapur | www.ambujacement.com |
Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives.
Ambuja Cements Limited Fundamentals Summary
| AMBUJACEM fundamental statistics | |
|---|---|
| Market cap | ₹1.41t |
| Earnings (TTM) | ₹29.74b |
| Revenue (TTM) | ₹328.50b |
47.3x
P/E Ratio4.3x
P/S RatioIs AMBUJACEM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBUJACEM income statement (TTM) | |
|---|---|
| Revenue | ₹328.50b |
| Cost of Revenue | ₹137.43b |
| Gross Profit | ₹191.08b |
| Other Expenses | ₹161.34b |
| Earnings | ₹29.74b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | 12.07 |
| Gross Margin | 58.17% |
| Net Profit Margin | 9.05% |
| Debt/Equity Ratio | 0.07% |
How did AMBUJACEM perform over the long term?
See historical performance and comparison